These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20359536)

  • 21. Restoring p53 in cancer: the promises and the challenges.
    Lozano G
    J Mol Cell Biol; 2019 Jul; 11(7):615-619. PubMed ID: 31283825
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer metabolism pipeline breaks new ground.
    Mullard A
    Nat Rev Drug Discov; 2016 Nov; 15(11):735-737. PubMed ID: 27807357
    [No Abstract]   [Full Text] [Related]  

  • 23. p53 as a target in myeloproliferative neoplasms.
    Lu M; Hoffman R
    Oncotarget; 2012 Oct; 3(10):1052-3. PubMed ID: 23165648
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenges in drug development for children.
    Adamson PC
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):26-29. PubMed ID: 28212366
    [No Abstract]   [Full Text] [Related]  

  • 25. The molecular mechanism of glucose metabolism hampered by p53 tumor suppressor protein.
    Kawauchi K
    J Nippon Med Sch; 2010 Feb; 77(1):48-9. PubMed ID: 20154459
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in Drug Discovery for the Treatment of Cancer: Many Approaches, One Goal.
    Bowen JP; Zhong HA
    Curr Top Med Chem; 2016; 16(13):1411-2. PubMed ID: 26957106
    [No Abstract]   [Full Text] [Related]  

  • 27. The canSAR data hub for drug discovery.
    Chau CH; O'Keefe BR; Figg WD
    Lancet Oncol; 2016 Mar; 17(3):286. PubMed ID: 26972856
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenging paradigms in tumour drug delivery.
    Nat Mater; 2020 May; 19(5):477. PubMed ID: 32332992
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug discovery: Fresh target for cancer therapy.
    Deshaies RJ
    Nature; 2009 Apr; 458(7239):709-10. PubMed ID: 19360071
    [No Abstract]   [Full Text] [Related]  

  • 30. Challenges in the Discovery of Novel Therapeutic Agents for Cancer Treatment (Part IV).
    Nagaraju GP; Kamal MA
    Curr Drug Metab; 2020; 21(3):165-166. PubMed ID: 32608350
    [No Abstract]   [Full Text] [Related]  

  • 31. Preface: oncometabolism: a new field of research with profound therapeutic implications.
    Galluzzi L; Kroemer G
    Methods Enzymol; 2014; 543():xv-xix. PubMed ID: 24924141
    [No Abstract]   [Full Text] [Related]  

  • 32. Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action.
    Mrozek-Wilczkiewicz A; Spaczynska E; Malarz K; Cieslik W; Rams-Baron M; Kryštof V; Musiol R
    PLoS One; 2015; 10(11):e0142678. PubMed ID: 26599982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic targeting of p53 by small molecules.
    Selivanova G
    Semin Cancer Biol; 2010 Feb; 20(1):46-56. PubMed ID: 20206268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating the p53 pathway.
    Dey A; Lane DP; Verma CS
    Semin Cancer Biol; 2010 Feb; 20(1):3-9. PubMed ID: 20193765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug discovery in the p53 field.
    Lain S
    Semin Cancer Biol; 2010 Feb; 20(1):1-2. PubMed ID: 20359536
    [No Abstract]   [Full Text] [Related]  

  • 36. The discovery of nongenotoxic activators of p53: building on a cell-based high-throughput screen.
    McCarthy AR; Hollick JJ; Westwood NJ
    Semin Cancer Biol; 2010 Feb; 20(1):40-5. PubMed ID: 20206696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent patents related to p53.
    Nat Rev Drug Discov; 2014 Mar; 13(3):169. PubMed ID: 24577392
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.